Stay updated on Nivolumab in AML Prevention Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.

Latest updates to the Nivolumab in AML Prevention Clinical Trial page
- Check2 days agoChange DetectedThe page now states 'No longer looking for participants', indicating the REMAIN trial is not currently enrolling. This reflects a shift in recruitment status for the AML maintenance study and affects potential participants' ability to join.SummaryDifference0.3%

- Check9 days agoChange DetectedA new Sample Collection section was added. The protocol was updated to Revision v3.5.5, replacing v3.5.4.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision tag has been updated from v3.5.3 to v3.5.4, indicating a newer version of the site's underlying platform. This change represents a version upgrade rather than a modification to visible content.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s footer revision identifier was updated from v3.5.2 to v3.5.3, reflecting a site/version maintenance update.SummaryDifference0.0%

- Check59 days agoChange DetectedA new update entry was added on 2026-04-13 with Revision: v3.5.2; the prior entries from 2026-04-08 and 2025-10, along with Revision: v3.5.0, were removed.SummaryDifference0.2%

- Check66 days agoChange DetectedLast update entries were added for 2026-04-09 and 2026-04-08, and earlier dates 2026-04-01 and 2026-04-02 were removed. These are administrative timestamp updates and do not change trial content or eligibility criteria.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.